Phase 3 trial of Biogen and UCB's dapirolizumab pegol shows significant improvement in lupus disease activity. Read more here ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...

Biopharma Leaders of Color (BLOC), a 501(c)(3) non-profit organization dedicated to promoting the professional advancement of people of color and growing the representation of leaders from ...

Medline today announced that it has expanded its medical surgical prime vendor agreement with Northern California-based ...

RFK Jr.’s main claim to fame, apart from his ancestry, is from saying crazy things about vaccines. As has been well-documented, vaccines have not led to ...

CareMessage, the largest patient activation platform in the United States for underserved populations, today announced the launch of their AI Assistant, adding ethical AI tools to their market-leading ...

Baler, Aurora, Philippines Video Recording Date/Time: November 17, 2024 at 15:35h Super Typhoon Man-Yi, known locally as Pepito, made its second landfall in Dipaculao, Aurora, at 3:20 p.m. on Sunday, ...

Biogen and UCB on Tuesday shared an expanded dataset for their Phase 3 lupus program, which they said two months ago ...

Failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells ...